Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesAsset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in IntangiblesChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Exchange Rate EffectFree Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

10x Genomics (TXG) Exchange Rate Effect (2018 - 2025)

10x Genomics (TXG) has disclosed Exchange Rate Effect for 8 consecutive years, with $43000.0 as the latest value for Q4 2025.

  • Quarterly Exchange Rate Effect rose 115.99% to $43000.0 in Q4 2025 from the year-ago period, while the trailing twelve-month figure was $484000.0 through Dec 2025, up 395.12% year-over-year, with the annual reading at $484000.0 for FY2025, 395.12% up from the prior year.
  • Exchange Rate Effect hit $43000.0 in Q4 2025 for 10x Genomics, up from -$33000.0 in the prior quarter.
  • In the past five years, Exchange Rate Effect ranged from a high of $360000.0 in Q2 2025 to a low of -$269000.0 in Q4 2024.
  • Historically, Exchange Rate Effect has averaged $23850.0 across 5 years, with a median of $1500.0 in 2021.
  • Biggest five-year swings in Exchange Rate Effect: tumbled 3300.0% in 2022 and later surged 12100.0% in 2025.
  • Year by year, Exchange Rate Effect stood at -$82000.0 in 2021, then soared by 406.1% to $251000.0 in 2022, then tumbled by 69.32% to $77000.0 in 2023, then plummeted by 449.35% to -$269000.0 in 2024, then surged by 115.99% to $43000.0 in 2025.
  • Business Quant data shows Exchange Rate Effect for TXG at $43000.0 in Q4 2025, -$33000.0 in Q3 2025, and $360000.0 in Q2 2025.